Literature DB >> 19079367

Cardiac amyloidosis, a monoclonal gammopathy and a potentially misleading mutation.

Ashutosh D Wechalekar1, Mark Offer, Julian D Gillmore, Philip N Hawkins, Helen J Lachmann.   

Abstract

BACKGROUND: A 46-year-old Afro-Caribbean man presented with progressive dyspnea and recurrent syncope. Clinical examination revealed evidence of biventricular failure. INVESTIGATIONS: Electrocardiography, echocardiography, cardiac biopsy, measurement of serum levels of free light chain, scintigraphy with radiolabeled serum amyloid P component, transthyretin gene sequencing and immunohistochemistry. DIAGNOSIS: Cardiac acquired monoclonal immunoglobulin-light-chain amyloidosis with the incidental presence of the amyloidogenic transthyretin Val122Ile mutation. MANAGEMENT: The patient was referred for consideration of urgent cardiac transplantation and subsequent autologous stem cell transplantation. Unfortunately, he died suddenly within a few weeks of referral.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19079367     DOI: 10.1038/ncpcardio1423

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  18 in total

1.  Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.

Authors:  D R Jacobson; R D Pastore; R Yaghoubian; I Kane; G Gallo; F S Buck; J N Buxbaum
Journal:  N Engl J Med       Date:  1997-02-13       Impact factor: 91.245

2.  Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin.

Authors:  C Aprile; G Marinone; R Saponaro; C Bonino; G Merlini
Journal:  Eur J Nucl Med       Date:  1995-12

3.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

4.  The classification of amyloid deposits in clinicopathological practice.

Authors:  C Röcken; E B Schwotzer; R P Linke; W Saeger
Journal:  Histopathology       Date:  1996-10       Impact factor: 5.087

Review 5.  Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis.

Authors:  Per Westermark; Merrill D Benson; Joel N Buxbaum; Alan S Cohen; Blas Frangione; Shu-Ichi Ikeda; Colin L Masters; Giampaolo Merlini; Maria J Saraiva; Jean D Sipe
Journal:  Amyloid       Date:  2005-03       Impact factor: 7.141

6.  Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.

Authors:  Falk-Udo Sack; Arnt Kristen; Hartmut Goldschmidt; Philipp A Schnabel; Thomas Dengler; Achim Koch; Matthias Karck
Journal:  Eur J Cardiothorac Surg       Date:  2007-12-21       Impact factor: 4.191

7.  High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.

Authors:  Arnaud Jaccard; Philippe Moreau; Veronique Leblond; Xavier Leleu; Lotfi Benboubker; Olivier Hermine; Christian Recher; Bouchra Asli; Bruno Lioure; Bruno Royer; Fabrice Jardin; Frank Bridoux; Bernard Grosbois; Jérome Jaubert; Jean-Charles Piette; Pierre Ronco; Fabrice Quet; Michel Cogne; Jean-Paul Fermand
Journal:  N Engl J Med       Date:  2007-09-13       Impact factor: 91.245

8.  Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy.

Authors:  Helen J Lachmann; Ruth Gallimore; Julian D Gillmore; Hugh D Carr-Smith; Arthur R Bradwell; Mark B Pepys; Philip N Hawkins
Journal:  Br J Haematol       Date:  2003-07       Impact factor: 6.998

9.  Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis.

Authors:  I M Hamour; H J Lachmann; H J B Goodman; M Petrou; M M Burke; P N Hawkins; N R Banner
Journal:  Am J Transplant       Date:  2008-03-02       Impact factor: 8.086

10.  Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.

Authors:  Arnt V Kristen; Thomas J Dengler; Ute Hegenbart; Stefan O Schonland; Hartmut Goldschmidt; Falk-Udo Sack; Frederik Voss; Rüdiger Becker; Hugo A Katus; Alexander Bauer
Journal:  Heart Rhythm       Date:  2007-10-09       Impact factor: 6.343

View more
  5 in total

1.  Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.

Authors:  Marc K Halushka; George Eng; A Bernard Collins; Daniel P Judge; Marc J Semigran; James R Stone
Journal:  J Cardiovasc Transl Res       Date:  2015-04-30       Impact factor: 4.132

2.  siRNA targeting the κ light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases.

Authors:  X Ma; P Zhou; S W Wong; M Warner; C Chaulagain; R L Comenzo
Journal:  Gene Ther       Date:  2016-06-20       Impact factor: 5.250

3.  Coexistence of Positive 99mTc-DPD Scintigraphy and Monoclonal Gammopathy: A Frequent Challenge.

Authors:  Ana Roteta Unceta-Barrenechea; Jorge Melero Polo; Alejandro Andrés Gracia; Pablo Revilla Martí; Sebastian Menao Guillén; Carmen Lahuerta Pueyo; Raquel Pérez-Palacios; Inmaculada Moreno Gázquez; Anyuli Gracia Gutiérrez; Miguel Ángel Aibar Arregui
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

4.  Late-onset Familial Amyloidotic Polyneuropathy with Bence Jones Proteinuria and Cardiomyopathy.

Authors:  Sira Carrasco García de León; Amalia Hernández González; Carmen Orellana Alonso; Laura Burriel Lobo
Journal:  J Neurosci Rural Pract       Date:  2017 Jul-Sep

5.  Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis.

Authors:  Joon Young Hur; Sang Eun Yoon; Darae Kim; Jin-Oh Choi; Ju-Hong Min; Byung Jun Kim; Jung Sun Kim; Jung Eun Lee; Joon Young Choi; Eun-Seok Jeon; Seok Jin Kim; Kihyun Kim
Journal:  Blood Res       Date:  2021-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.